Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,761
archived clinical trials in
Osteoporosis

VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Concord, CA
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Concord, CA
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Fresno, CA
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Laguna Hills, CA
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Lancaster, CA
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Lancaster, CA
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Tustin, CA
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Tustin, CA
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Lakewood, CO
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Lakewood, CO
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Danbury, CT
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Danbury, CT
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Orlando, FL
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Gainesville, GA
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Gainesville, GA
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Evansville, IN
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Indianapolis, IN
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Topeka, KA
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Bethesda, MD
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Detroit, MI
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Omaha, NE
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Clifton, NJ
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Clifton, NJ
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Freehold, NJ
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Freehold, NJ
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Albuquerque, NM
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Asheville, NC
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Asheville, NC
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Greensboro, NC
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Greensboro, NC
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Fargo, ND
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Fargo, ND
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Bend, OR
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Bend, OR
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Duncansville, PA
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Pittsburgh, PA
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Wyomissing, PA
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Wyomissing, PA
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Dallas, TX
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Seattle, WA
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Spokane, WA
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Madison, WI
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
mi
from
Buenos Aires,
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
mi
from
Buenos Aires,
Click here to add this to my saved trials
Bone Histomorphometry in Subjects Undergoing Total Hip Replacement
Bone Histomorphometry of the Proximal Femur in Denosumab-treated Subjects Undergoing Total Hip Replacement
Status: Enrolling
Updated:  1/26/2018
Helen Hayes Hospital
mi
from
West Haverstraw, NY
Bone Histomorphometry in Subjects Undergoing Total Hip Replacement
Bone Histomorphometry of the Proximal Femur in Denosumab-treated Subjects Undergoing Total Hip Replacement
Status: Enrolling
Updated: 1/26/2018
Helen Hayes Hospital
mi
from
West Haverstraw, NY
Click here to add this to my saved trials
Bone Histomorphometry in Subjects Undergoing Total Hip Replacement
Bone Histomorphometry of the Proximal Femur in Denosumab-treated Subjects Undergoing Total Hip Replacement
Status: Enrolling
Updated:  1/26/2018
Clinical Research Facility
mi
from
West Haverstraw, NY
Bone Histomorphometry in Subjects Undergoing Total Hip Replacement
Bone Histomorphometry of the Proximal Femur in Denosumab-treated Subjects Undergoing Total Hip Replacement
Status: Enrolling
Updated: 1/26/2018
Clinical Research Facility
mi
from
West Haverstraw, NY
Click here to add this to my saved trials
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Irvine, CA
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Irvine, CA
Click here to add this to my saved trials
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Loma Linda, CA
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Loma Linda, CA
Click here to add this to my saved trials
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Los Angeles, CA
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Oakland, CA
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Oakland, CA
Click here to add this to my saved trials
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Rancho Mirage, CA
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Lakewood, CO
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Lakewood, CO
Click here to add this to my saved trials
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Gainesville, FL
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Bethesda, MD
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Wheaton, MD
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Wheaton, MD
Click here to add this to my saved trials
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Billings, MT
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Billings, MT
Click here to add this to my saved trials
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Omaha, NE
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Livingston, NJ
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Livingston, NJ
Click here to add this to my saved trials
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Albuquerque, NM
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Portland, OR
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Wyomissing, PA
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Wyomissing, PA
Click here to add this to my saved trials
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
San Antonio, TX
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Richmond, VA
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Seattle, WA
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials